Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Ebiomedicine|October 30, 2016
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor ImmunityLiqing Wang, Suresh Kumar, Satinder Dahiya, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic ActivityJarrod D Predina, Andrew R Haas, Marina Martinez, et al.
Cancer Research Communications|May 7, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural MesotheliomaGwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas, et al.
JCI Insight|December 20, 2019
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLCJulia Kargl, Xiaodong Zhu, Huajia Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responsesDaniel H Sterman, Adri Recio, Richard G Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Ebiomedicine|October 30, 2016
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor ImmunityLiqing Wang, Suresh Kumar, Satinder Dahiya, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic ActivityJarrod D Predina, Andrew R Haas, Marina Martinez, et al.
Cancer Research Communications|May 7, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural MesotheliomaGwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas, et al.
JCI Insight|December 20, 2019
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLCJulia Kargl, Xiaodong Zhu, Huajia Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responsesDaniel H Sterman, Adri Recio, Richard G Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 20